Company Description

Mangoceuticals, Inc. develops, markets, and sells various men’s wellness products and services through a telemedicine platform in the United States.

It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name.

The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com.

Mangoceuticals, Inc. has a marketing agreement with Marius Pharmaceuticals, LLC to market and sell KYZATREX, an oral testosterone replacement therapy product under the PRIME program.

The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.

Mangoceuticals, Inc.

Country	United States
Founded	2021
IPO Date	Mar 21, 2023
Industry	Health Information Services
Sector	Healthcare
Employees	3
CEO	Jacob Cohen

Contact Details

Address: 15110 North Dallas Parkway, Suite 600 Dallas, Texas 75248 United States
Phone	214 242 9619
Website	mangoceuticals.com

Stock Details

Ticker Symbol	MGRX
Exchange	NASDAQ
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	USD
IPO Price	$4.00
CIK Code	0001938046
CUSIP Number	56270V106
ISIN Number	US56270V1061
Employer ID	87-3841292
SIC Code	8090

Key Executives

Name	Position
Jacob D. Cohen	Co-Founder, Chief Executive Officer and Chairman

Latest SEC Filings

Date	Type	Title
Mar 28, 2025	8-K	Current Report
Mar 25, 2025	8-K	Current Report
Mar 20, 2025	10-K	Annual Report
Mar 19, 2025	8-K	Current Report
Feb 19, 2025	8-K	Current Report
Feb 18, 2025	DEF 14A	Other definitive proxy statements
Feb 12, 2025	8-K	Current Report
Feb 12, 2025	8-K	Current Report
Feb 10, 2025	424B3	Prospectus
Feb 10, 2025	424B3	Prospectus

View All SEC Filings